Thyroid carcinoma
Information
- Disease name
- Thyroid carcinoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02185560 | Active, not recruiting | Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib | June 27, 2014 | June 30, 2024 | |
| NCT02145143 | Active, not recruiting | N/A | Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study | May 2014 | May 2025 |
| NCT06439745 | Completed | More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated | September 1, 2014 | February 1, 2024 | |
| NCT00510640 | Completed | Phase 2 | Thyroid Cancer and Sunitinib | August 2007 | March 2012 |
| NCT01013597 | Completed | Phase 2 | Trial of LBH589 in Metastatic Thyroid Cancer | January 2010 | February 2016 |
| NCT01126060 | Completed | Phase 3 | Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy Drain | February 2010 | January 2011 |
| NCT01433809 | Completed | Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm | June 2011 | May 2013 | |
| NCT01487057 | Completed | Lipid Metabolic Status in Thyroid Carcinoma | February 2011 | May 2012 | |
| NCT01813136 | Completed | Phase 2 | Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma | March 2013 | January 2019 |
| NCT02114658 | Completed | Phase 2 | Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients | April 15, 2014 | August 2, 2016 |
| NCT02194920 | Completed | Parathyroid Reimplantation in Forearm Subcutaneous Tissue During Thyroidectomy: a Simple Way to Avoid Ipoparathyroidism and Evaluate Graft Function | October 2014 | November 2014 | |
| NCT02614495 | Completed | Phase 2 | Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma | February 24, 2016 | September 30, 2018 |
| NCT02658513 | Completed | Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | September 2016 | March 2019 | |
| NCT02773667 | Completed | Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine | January 2016 | December 2022 | |
| NCT04462471 | Completed | Phase 1 | Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers | June 26, 2020 | September 29, 2023 |
| NCT04922801 | Completed | Optimising Molecular Radionuclide Therapy | December 9, 2021 | November 5, 2022 | |
| NCT05178186 | Completed | N/A | Impact of the COVID-19 Pandemic on Surgery for Thyroid Cancer | June 20, 2022 | September 15, 2022 |
| NCT00215605 | Completed | Phase 1 | Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies | September 2005 | July 2012 |
| NCT06095362 | Enrolling by invitation | Phase 1 | Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW | November 29, 2021 | October 2023 |
| NCT05949424 | Not yet recruiting | Phase 4 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults | May 2024 | March 2025 |
| NCT06146764 | Not yet recruiting | CEUS Improves the Diagnostic Performance of SRSS of Thyroid Carcinoma | January 1, 2024 | April 15, 2024 | |
| NCT03647358 | Recruiting | Phase 1 | Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma | August 21, 2018 | August 2026 |
| NCT03942380 | Recruiting | N/A | Cell-free Tumor DNA in Head and Neck Cancer Patients | February 1, 2017 | February 1, 2025 |
| NCT05786924 | Recruiting | Phase 1 | A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers | April 18, 2023 | December 2026 |
| NCT05796960 | Recruiting | European Multicenter Study on Surgical Management of Advanced Thyroid Cancer | December 15, 2022 | September 2023 | |
| NCT03382158 | Recruiting | International PPB/DICER1 Registry | December 6, 2016 | December 6, 2035 | |
| NCT04666103 | Recruiting | N/A | Function Integrity of Neck Anatomy in Thyroid Surgery | December 11, 2020 | December 12, 2026 |
| NCT04802876 | Recruiting | Phase 2 | Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors | April 12, 2021 | March 31, 2027 |
| NCT06270082 | Recruiting | Phase 1 | Study of IK-595 in RAS- or RAF-altered Advanced Tumors | December 18, 2023 | July 2027 |
| NCT05668962 | Recruiting | Phase 2 | Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC | March 1, 2023 | January 1, 2025 |
| NCT02628067 | Recruiting | Phase 2 | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) | December 18, 2015 | May 4, 2027 |
| NCT01865838 | Terminated | N/A | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | May 2013 | September 2014 |
| NCT00647140 | Terminated | Phase 2 | Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer | August 2007 | February 2010 |
| NCT04327999 | Terminated | Phase 2 | Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System | October 5, 2020 | September 25, 2023 |
| NCT00993837 | Unknown status | N/A | Feasibility of Endoscopic Thyroidectomy for Thyroid Carcinoma | January 2010 | June 2012 |
| NCT04411290 | Unknown status | Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases | May 15, 2020 | June 1, 2021 | |
| NCT00929318 | Unknown status | N/A | Influence of Thyroid Hormones on the Woundhealing Process | June 2009 | April 2010 |
| NCT03500666 | Unknown status | N/A | Comparative Study of Robot BABA Approach and Chest Breast Approach for Lateral Neck Dissection | January 1, 2018 | December 31, 2018 |
| NCT00749697 | Unknown status | N/A | Radioiodine Dosimetry Protocol for Thyroid Cancer Metastases | May 2008 | July 2010 |
| NCT01707056 | Withdrawn | N/A | The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma | September 2012 | June 2016 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002890